(Q40209539)

18 September 2017

title

Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening (English)

1 reference

18 September 2017

0 references

0 references

1 reference

Feng Ge

1

1 reference

18 September 2017

Yonghu Luo

series ordinal

2

1 reference

18 September 2017

Pei Xiong Liew

series ordinal

3

1 reference

18 September 2017

Eugene Hung

series ordinal

4

1 reference

18 September 2017

language of work or name

English

0 references

publication date

13 November 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

360

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

150-158

1 reference

The nucleoprotein is required for efficient coronavirus genome replication.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Transcription regulatory sequences and mRNA expression levels in the coronavirus transmissible gastroenteritis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Hepatitis C virus replicons: potential role for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Heterologous gene expression from transmissible gastroenteritis virus replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Aetiology: Koch's postulates fulfilled for SARS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Coronavirus transcription mediated by sequences flanking the transcription consensus sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

A novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Potential High-Throughput Assay for Screening Inhibitors of West Nile Virus Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Development of Dengue virus type 2 replicons capable of prolonged expression in host cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Coronavirus as a possible cause of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

The severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Identification of severe acute respiratory syndrome in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Construction and characterization of subgenomic replicons of New York strain of West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

The Biology of Coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Development of a standard treatment protocol for severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Feline calicivirus: recovery of wild-type and recombinant viruses after transfection of cRNA or cDNA constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Small molecules targeting severe acute respiratory syndrome human coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

Characterization of an autonomous subgenomic pestivirus RNA replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Construction and characterization of poliovirus subgenomic replicons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Subgenomic replicons of the flavivirus Kunjin: construction and applications

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17098272

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.10.016

1 reference

18 September 2017

1 reference